NOVODX – At-Home Diagnostics and Venture-Backed Growth
Date
February 5, 2023
Share
Since February 2023, NOVODX has focused on developing and commercializing rapid at-home diagnostics, including a miniaturized immunofluorescence reader and CLIA-waived tests. Headquartered in Florida, the company is backed by prominent investors and advisors.
Role
Financial Economist — leading financial modeling, cash flow planning, and scenario analysis for fundraising and international expansion.
Highlights
Supported multi-million equity raises in diagnostics.
Built cash flow and scenario models for U.S., Africa, and LATAM market entry.
Partnered with management on competitive analysis and pricing strategies.
